Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments.Neuron. 2019; 102: 75-90
- Monotherapy with major antihypertensive drug classes and risk of hospital admissions for mood disorders.Hypertension. 2016; 68: 1132-1138
- Angiotensin-converting enzyme inhibitor rapidly ameliorates depressive-type behaviors via bradykinin-dependent activation of mammalian target of rapamycin complex 1.Biol Psychiatry. 2020; 88: 415-425
- Optogenetic stimulation of infralimbic PFC reproduces ketamine’s rapid and sustained antidepressant actions.Proc Natl Acad Sci U S A. 2015; 112: 8106-8111
- mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.Science. 2010; 329: 959-964
- Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation.Science. 2019; 364: 1-11
- Two cellular hypotheses explaining the initiation of ketamine’s antidepressant actions: Direct inhibition and disinhibition.Neuropharmacology. 2016; 100: 17-26
- Genome-wide atlas of gene expression in the adult mouse brain.Nature. 2007; 445: 168-176
- In vivo effects of bradykinin B2 receptor agonists with varying susceptibility to peptidases.Front Pharmacol. 2015; 6: 1-15
- Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin.Neuropsychopharmacology. 2020; 45: 990-997